Department of Neurology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233004, China.
BMC Neurol. 2024 Aug 26;24(1):296. doi: 10.1186/s12883-024-03781-2.
The objective of this study was to establish a predictive model utilizing machine learning techniques to anticipate the likelihood of thrombolysis resistance (TR) in acute ischaemic stroke (AIS) patients undergoing recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis, given that nearly half of such patients exhibit poor clinical outcomes.
Retrospective clinical data were collected from AIS patients who underwent intravenous thrombolysis with rt-PA at the First Affiliated Hospital of Bengbu Medical University. Thrombolysis resistance was defined as ([National Institutes of Health Stroke Scale (NIHSS) at admission - 24-hour NIHSS] × 100%/ NIHSS at admission) ≤ 30%. In this study, we developed five machine learning models: logistic regression (LR), extreme gradient boosting (XGBoost), support vector machine (SVM), the least absolute shrinkage and selection operator (LASSO), and random forest (RF). We assessed the model's performance by using receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA), and presented the results through a nomogram.
This study included a total of 218 patients with AIS who were treated with intravenous thrombolysis, 88 patients experienced TR. Among the five machine learning models, the LASSO model performed the best. The area under the curve (AUC) on the testing group was 0.765 (sensitivity: 0.767, specificity: 0.694, accuracy: 0.727). The apparent curve in the calibration curve was similar to the ideal curve, and DCA showed a positive net benefit. Key features associated with TR included NIHSS at admission, blood glucose, white blood cell count, neutrophil count, and blood urea nitrogen.
Machine learning methods with multiple clinical variables can help in early screening of patients at high risk of thrombolysis resistance, particularly in contexts where healthcare resources are limited.
本研究旨在利用机器学习技术建立一个预测模型,预测接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗的急性缺血性脑卒中(AIS)患者发生溶栓抵抗(TR)的可能性,因为近一半的此类患者临床预后较差。
回顾性收集蚌埠医学院第一附属医院接受 rt-PA 静脉溶栓治疗的 AIS 患者的临床资料。溶栓抵抗定义为[入院时美国国立卫生研究院卒中量表(NIHSS)-24 小时 NIHSS]×100%/ NIHSS 入院时≤30%。本研究建立了 5 种机器学习模型:逻辑回归(LR)、极端梯度提升(XGBoost)、支持向量机(SVM)、最小绝对收缩和选择算子(LASSO)和随机森林(RF)。我们通过接受者操作特征曲线(ROC)、校准曲线和决策曲线分析(DCA)评估模型性能,并通过列线图展示结果。
本研究共纳入 218 例接受静脉溶栓治疗的 AIS 患者,88 例患者发生 TR。在 5 种机器学习模型中,LASSO 模型表现最佳。在测试组中的曲线下面积(AUC)为 0.765(灵敏度:0.767,特异性:0.694,准确性:0.727)。校准曲线中的明显曲线与理想曲线相似,DCA 显示出正的净获益。与 TR 相关的关键特征包括入院时 NIHSS、血糖、白细胞计数、中性粒细胞计数和血尿素氮。
具有多个临床变量的机器学习方法可以帮助早期筛选溶栓抵抗风险较高的患者,特别是在医疗资源有限的情况下。